According to Future Market Insights (FMI), the global lung cancer surgery market is projected to grow from USD 1.6 billion in 2026 to USD 2.8 billion by 2036, expanding at a 5.9% CAGR during the forecast period. The market is expected to create an incremental opportunity of USD 1.2 billion between 2026 and 2036 as earlier-stage diagnosis, minimally invasive procedures, and robotic-assisted...

The lung cancer surgery market continues to gain momentum as surgical innovations and early diagnosis improve survival outcomes. Industry trends demonstrate steady growth driven by technological advancements and rising incidence rates worldwide. Understanding the interplay between market dynamics and regional factors is key to capitalizing on emerging market opportunities. Market Size and...

NEWARK, Del., USA, JUNE 15, 2026 — According to the latest analysis by Future Market Insights (FMI), the global Lung Cancer Surgery Market is expected to witness steady growth over the next decade, driven by rising early-stage lung cancer diagnosis, increasing adoption of minimally invasive surgical techniques, and growing investments in advanced thoracic surgical technologies. As...

According to the latest analysis by Future Market Insights (FMI), the global Non-Small Cell Lung Cancer (NSCLC) Market is expected to witness strong growth over the next decade, driven by increasing lung cancer prevalence, advancements in precision medicine, expanding adoption of targeted therapies, and rising investments in oncology research. As healthcare systems increasingly focus on early...

NEWARK, Del., October 5, 2026 — According to Future Market Insights (FMI), the global reusable laparoscopic instruments market is projected to reach USD 8.7 billion by 2036, up from USD 5.5 billion in 2026, expanding at a 4.7% CAGR from 2026 to 2036. The market was valued at USD 5.3 billion in 2025. Growth is being supported by hospitals seeking to reduce per-case instrument costs through...